Your browser doesn't support javascript.
loading
Did patients with COVID-19 receive timely treatment in the early epidemic?-a systematic review and meta-analysis.
Du, Peipei; Chen, Weixiang; Luo, Xufei; Chen, Yaolong; Shi, Qianling; Lv, Meng; Wang, Jie; Shi, Xuemei; Ma, Xiaofeng; Yang, Tianying; Lu, Shuya; Li, Tingting; Yang, Xiaokun; Yang, Shu; Feng, Xixi.
Afiliación
  • Du P; College of Medical Information Engineering, Chengdu University of Traditional Chinese Medicine, Chengdu, China; School of Public Health, Chengdu Medical College, Chengdu, China.
  • Chen W; College of Medical Information Engineering, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Luo X; School of Public Health, Lanzhou University, Lanzhou, China.
  • Chen Y; Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China; WHO Collaborating Centre for Guideline Implementation and Knowledge Translation, Lanzhou, China; GIN (Guidelines International Network) Asia, Lanzhou, China; Key Laboratory of Evidence Based Medicin
  • Shi Q; The First School of Clinical Medicine, Lanzhou University, Lanzhou, China.
  • Lv M; School of Public Health, Lanzhou University, Lanzhou, China.
  • Wang J; School of Public Health, Chengdu Medical College, Chengdu, China.
  • Shi X; School of Clinical Medicine, Chengdu Medical College, Chengdu, China.
  • Ma X; School of Public Health, Chengdu Medical College, Chengdu, China.
  • Yang T; The Second School of Clinical Medicine, Chongqing Medical University, Chongqing, China.
  • Lu S; Department of Pediatric, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China; Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China.
  • Li T; School of Pharmacy, Chengdu Medical College, Chengdu, China.
  • Yang X; Department of Emergency Medicine, The General Hospital of Western Theater Command of PLA, Chengdu, China.
  • Yang S; College of Medical Information Engineering, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Feng X; School of Public Health, Chengdu Medical College, Chengdu, China.
Ann Palliat Med ; 11(2): 452-465, 2022 Feb.
Article en En | MEDLINE | ID: mdl-34775768
BACKGROUND: Corona virus disease 2019 (COVID-19) showed a significant difference in case fatality rate between different regions at the early stage of the epidemic. In addition to the well-known factors such as age structure, detection efficiency, and race, there was also a possibility that medical resource shortage caused the increase of the case fatality rate in some regions. METHODS: Medline, Cochrane Library, Embase, Web of Science, CBM, CNKI, and Wanfang of identified articles were searched through 29 June 2020. Cohort studies and case series with duration information on COVID-19 patients were included. Two independent reviewers extracted the data using a standardized data collection form and assessed the risk of bias. Data were synthesized through description and analysis methods including a meta-analysis. RESULTS: A total of 109 articles were retrieved. The time interval from onset to the first medical visit of COVID-19 patients in China was 3.38±1.55 days (corresponding intervals in Hubei province, non-Hubei provinces, Wuhan, Hubei provinces without Wuhan were 4.22±1.13, 3.10±1.57, 4.20±0.97, and 4.34±1.72 days, respectively). The time interval from onset to the hospitalization of COVID-19 patients in China was 8.35±6.83 days (same corresponding intervals were 12.94±7.43, 4.17±1.45, 14.86±7.12, and 5.36±1.19 days, respectively), and when it was outside China, this interval was 5.27±1.19 days. DISCUSSION: In the early stage of the COVID-19 epidemic, patients with COVID-19 did not receive timely treatment, resulting in a higher case fatality rate in Hubei province, partly due to the relatively insufficient and unequal medical resources. This research suggested that additional deaths caused by the out-of-control epidemic can be avoided if prevention and control work is carried out at the early stage of the epidemic. TRIAL REGISTRATION: CRD42020195606.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Ann Palliat Med Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Ann Palliat Med Año: 2022 Tipo del documento: Article País de afiliación: China